AKT inhibitors in gynecologic oncology: past, present and future by Jinghong Chen, Rutie Yin

Subjects: “…AKT inhibitor…”
Get full text

Carrier-free nano-integrated strategy of phototherapy and chemotherapy for synergetic AKT targeted therapy to inhibit cancer metastasis and recurrence by Zhuoting Lu, Tong Wang, Xiangchi Xu, Qinglian Hu, Lei Wang, Yuanxiang Jin

Subjects: Get full text

Modulating NPC1L1 to Potentiate PARP Inhibitor-Induced Ferroptosis and Immune Response in Triple-Negative Breast Cancer by Ge Li, Yuxia Yuan, Xinhua Wu, Lixian Wu

Subjects: Get full text

Retrospective comparison between breast cancer tissue- and blood-based next-generation sequencing results in detection of PIK3CA, AKT1, and PTEN alterations by Moumita Chaki, Mona Benrashid, Subir Puri, Smruthy Sivakumar, Ethan S. Sokol, Josefa M. Briceno, Neil Vasan

Subjects: “…AKT inhibitor…”
Get full text

Modulation of intracellular kinase signaling to improve TIL stemness and function for adoptive cell therapy by Hao Feng, Ling Qiu, Zixiao Shi, Yao Sheng, Peipei Zhao, Di Zhou, Fei Li, Hailin Yu, Yanan You, Hui Wang, Ming Li, Shurong Zhu, Yan Du, Jun Cui, Jingwei Sun, Yarong Liu, Hua Jiang, Xin Wu

Subjects: “…AKT inhibitor…”
Get full text

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition) by The Breast Cancer Expert Committee of the National Quality Control Center for Cancer, The Expert Committee on Cancer Prevention and Treatment of the Health China Research Center, The Society of Clinical Research on Oncology Medications of the China Anti‐Cancer Association, The Society of Onco‐Pathology of the China Anti‐Cancer Association

Subjects: “…AKT inhibitor…”
Get full text